broxaterol has been researched along with Asthma in 20 studies
*Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 10 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianco, S; Gambaro, G; Lodola, E; Pisati, R; Robuschi, M; Scuri, M; Spagnotto, S | 1 |
| Benedetti, M; Boner, AL; Comis, A; Marcer, G; Spezia, E | 1 |
| Biasin, C; Ferrari, M; Lo Cascio, V; Lodola, E; Olivieri, M; Pisati, R | 1 |
| Pavord, ID; Tattersfield, AE; Wahedna, I; Wisniewski, AF; Wong, CS | 1 |
| Bresciani, E; Desenzani, P; Giustina, A; Grassi, V; Licini, M; Malerba, M; Zaltieri, G | 1 |
| Ganassini, A; Rossi, A | 1 |
| Ansalone, D; Gurrieri, G; Petraglia, A; Pisati, R; Scarpitta, M | 1 |
| Crippa, L; De Biase, D; Flores D'Arcais, A; Romagnoni, G | 1 |
| Bianco, S; Fai, V; Gambaro, G; Lodola, E; Pisati, R; Robuschi, M; Scuri, M; Spagnotto, S | 1 |
| Burni, B; Dottorini, ML; Grassi, V; Gurrieri, G; Malerba, M; Peccini, F; Sorbini, CA; Tantucci, C | 1 |
| Della Bella, D | 1 |
| Löfdahl, CG; Sigvaldasson, A; Skoogh, BE; Svedmyr, N | 1 |
| Bianco, S | 1 |
| Ziment, I | 1 |
| Allegra, L | 1 |
| Corsico, R; Lodola, E; Majani, U; Rampulla, C | 1 |
| Bianco, S; Robuschi, M; Simone, P; Vaghi, A; Ventresca, GP | 1 |
| Casali, L; Colombo, ML; Manazza, P; Rossi, A; Zoia, MC | 1 |
| Chetta, A; Cuomo, A; Garavaldi, G; Gurrieri, G; Olivieri, D | 1 |
3 review(s) available for broxaterol and Asthma
| Article | Year |
|---|---|
Broxaterol: pharmacological profile of a unique structural feature.
Topics: Adrenergic beta-Agonists; Animals; Asthma; Bronchodilator Agents; Humans; Isoxazoles; Oxazoles; Structure-Activity Relationship | 1989 |
Role of broxaterol in bronchial hyperresponsiveness.
Topics: Adrenergic beta-Agonists; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Bronchodilator Agents; Double-Blind Method; Humans; Isoxazoles; Oxazoles; Randomized Controlled Trials as Topic | 1989 |
Broxaterol: therapeutic trials and safety profile.
Topics: Adrenergic beta-Agonists; Adult; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Humans; Isoxazoles; Oxazoles; Randomized Controlled Trials as Topic | 1989 |
15 trial(s) available for broxaterol and Asthma
| Article | Year |
|---|---|
The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction.
Topics: Administration, Cutaneous; Adolescent; Adrenergic beta-Agonists; Asthma; Bronchoconstriction; Child; Cross-Over Studies; Double-Blind Method; Exercise; Female; Humans; Isoxazoles; Male | 1995 |
Preliminary study on the effect of broxaterol on bronchial hyperresponsiveness in asthmatic children: influence of allergen exposure.
Topics: Adolescent; Adrenergic beta-Agonists; Allergens; Asthma; Bronchial Hyperreactivity; Child; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Isoxazoles; Male; Maximal Midexpiratory Flow Rate; Peak Expiratory Flow Rate; Pilot Projects; Vital Capacity | 1993 |
Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Asthma; Blood Pressure; Bronchitis; Bronchodilator Agents; Double-Blind Method; Female; Forced Expiratory Volume; Heart Rate; Humans; Isoxazoles; Male; Maximal Expiratory Flow Rate; Middle Aged; Vital Capacity | 1993 |
Asthma control during and after cessation of regular beta 2-agonist treatment.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Asthma; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Isoxazoles; Male; Middle Aged; Peak Expiratory Flow Rate; Time Factors | 1993 |
Effect of two beta 2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bronchitis; Chronic Disease; Cross-Over Studies; Double-Blind Method; Exercise; Exercise Test; Female; Growth Hormone; Hormones; Humans; Isoxazoles; Male; Middle Aged | 1995 |
Short-term regular beta 2-adrenergic agonists treatment is safe in mild asthmatics taking low doses of inhaled steroids.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Adult; Asthma; Beclomethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Isoxazoles; Male; Middle Aged; Respiratory Mechanics; Vital Capacity | 1997 |
Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
Topics: Adrenergic beta-Agonists; Adult; Airway Resistance; Asthma; Blood Pressure; Bronchi; Bronchodilator Agents; Female; Forced Expiratory Volume; Heart Rate; Humans; Isoxazoles; Male; Middle Aged; Single-Blind Method; Terbutaline; Time Factors | 1992 |
Bronchodilating activity of broxaterol transdermal patch and its protective effect on bronchial constriction induced by inhaled distilled water mist.
Topics: Administration, Cutaneous; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Asthma; Bronchoconstriction; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Nebulizers and Vaporizers; Spirometry | 1991 |
Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Albuterol; Asthma; Double-Blind Method; Humans; Isoxazoles; Oxazoles; Randomized Controlled Trials as Topic | 1989 |
Role of broxaterol in bronchial hyperresponsiveness.
Topics: Adrenergic beta-Agonists; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Bronchodilator Agents; Double-Blind Method; Humans; Isoxazoles; Oxazoles; Randomized Controlled Trials as Topic | 1989 |
Broxaterol: therapeutic trials and safety profile.
Topics: Adrenergic beta-Agonists; Adult; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Humans; Isoxazoles; Oxazoles; Randomized Controlled Trials as Topic | 1989 |
Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Blood Pressure; Bronchitis; Clinical Trials as Topic; Double-Blind Method; Female; Forced Expiratory Volume; Heart Rate; Humans; Isoxazoles; Male; Middle Aged; Oxazoles; Pulse; Random Allocation; Spirometry; Time Factors | 1985 |
Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Asthma; Bronchi; Bronchitis; Bronchospirometry; Double-Blind Method; Drug Evaluation; Forced Expiratory Volume; Humans; Isoxazoles; Maximal Midexpiratory Flow Rate; Middle Aged; Oxazoles; Random Allocation; Vital Capacity | 1987 |
A comparison of the bronchodilator effects of broxaterol and salbutamol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Blood Pressure; Bronchodilator Agents; Female; Heart Rate; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Respiratory Function Tests; Time Factors | 1988 |
Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Asthma; Bronchodilator Agents; Female; Humans; Isoxazoles; Male; Middle Aged; Oxazoles | 1988 |
4 other study(ies) available for broxaterol and Asthma
| Article | Year |
|---|---|
[Pharmacokinetics of broxaterol in asthmatic children].
Topics: Adolescent; Adrenergic beta-Agonists; Asthma; Child; Female; Humans; Isoxazoles; Male | 1992 |
Acute ventilatory and gas-exchange effects of a new beta-2 agonist, broxaterol, in asthmatics.
Topics: Adrenergic beta-Agonists; Adult; Aged; Asthma; Female; Humans; Injections, Intravenous; Intermittent Positive-Pressure Breathing; Isoxazoles; Male; Middle Aged; Pulmonary Gas Exchange; Respiratory Function Tests | 1990 |
Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
Topics: Adrenergic beta-Agonists; Asthma; Bronchitis; Humans; Isoxazoles; Oxazoles | 1989 |
Remarks on broxaterol.
Topics: Adrenergic alpha-Agonists; Asthma; Bronchodilator Agents; Humans; Isoxazoles; Oxazoles | 1989 |